For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Acadia Healthcare Company Inc (NASDAQ: ACHC) closed at $17.15 up 3.50% from its previous closing price of $16.57. In other words, the price has increased by $3.50 from its previous closing price. On the day, 2.87 million shares were traded. ACHC stock price reached its highest trading level at $17.58 during the session, while it also had its lowest trading level at $16.425.
Ratios:
For a deeper understanding of Acadia Healthcare Company Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On August 14, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $26.
Barclays Downgraded its Overweight to Equal Weight on February 28, 2025, whereas the target price for the stock was revised from $43 to $35.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1583744000 and an Enterprise Value of 4083712512. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.55, and their Forward P/E ratio for the next fiscal year is 7.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at 1.251 whereas that against EBITDA is 6.515.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.93, which has changed by -0.57789814 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $47.08, while it has fallen to a 52-week low of $14.30. The 50-Day Moving Average of the stock is -20.87%, while the 200-Day Moving Average is calculated to be -29.54%.
Shares Statistics:
For the past three months, ACHC has traded an average of 2.88M shares per day and 2973030 over the past ten days. A total of 90.43M shares are outstanding, with a floating share count of 89.34M. Insiders hold about 3.16% of the company’s shares, while institutions hold 124.78% stake in the company. Shares short for ACHC as of 1763078400 were 11646543 with a Short Ratio of 4.05, compared to 1760486400 on 12102934. Therefore, it implies a Short% of Shares Outstanding of 11646543 and a Short% of Float of 15.010001.
Earnings Estimates
As of right now, 12.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.39, with high estimates of $0.47 and low estimates of $0.26.
Analysts are recommending an EPS of between $2.41 and $2.26 for the fiscal current year, implying an average EPS of $2.35. EPS for the following year is $2.23, with 11.0 analysts recommending between $2.48 and $1.74.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $801.84M this quarter.It ranges from a high estimate of $827.18M to a low estimate of $789M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $774.24MFor the next quarter, 12 analysts are estimating revenue of $817.16M. There is a high estimate of $835.1M for the next quarter, whereas the lowest estimate is $795.4M.
A total of 12 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.32B, while the lowest revenue estimate was $3.28B, resulting in an average revenue estimate of $3.29B. In the same quarter a year ago, actual revenue was $3.15BBased on 12 analysts’ estimates, the company’s revenue will be $3.43B in the next fiscal year. The high estimate is $3.48B and the low estimate is $3.34B.
